By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Northwest Biotherapeutics, Inc. 

21720 23rd Drive SE, Suite 100

Bothell  Washington  98021  U.S.A.
Phone: 425-608-3000-or-877-606-9246-Toll-Free Fax: 425-608-3026


SEARCH JOBS


Industry
Services


Collaborations

Cytogen Corporation  Development of ex vivo prostate cancer immunotherapy





Company News
Northwest Biotherapeutics (NWBO) Featured In Presentations At The AACR Annual Meeting 4/21/2015 1:17:27 PM
Northwest Biotherapeutics (NWBO) Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 4/16/2015 10:37:18 AM
Northwest Biotherapeutics (NWBO) Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" 4/16/2015 8:21:17 AM
Northwest Biotherapeutics (NWBO) To Present At World Vaccine Congress 2015 4/9/2015 8:08:22 AM
Northwest Biotherapeutics (NWBO) Announces $40 Million Financing 4/2/2015 10:18:10 AM
Northwest Biotherapeutics (NWBO) Reports Promising Survival Data In 51 Gbm Patients Treated With Dcvax-L 3/27/2015 7:24:57 AM
Northwest Biotherapeutics (NWBO) To Present At The 2nd Immunotherapy Of Cancer Conference, ITOC-2 3/24/2015 11:22:04 AM
Northwest Biotherapeutics (NWBO)'s Phase 3 Trial Of Dcvax-L For Gbm Brain Cancer Approved To Proceed In Canada And Under Way At Two Sites 2/19/2015 11:07:29 AM
Northwest Biotherapeutics (NWBO) To Present At 17th Annual BIO CEO & Investor Conference 2/9/2015 11:25:31 AM
Northwest Biotherapeutics (NWBO) To Present At The 7th Annual Phacilitate Immunotherapy Forum 1/23/2015 10:38:39 AM
12345678910...
//-->